findmyKOL
Clinical trialNCT01158157CompletedPhase 3Interventional

VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV

SponsorEmergent BioSolutionsEnrollment25Smallpox Vaccine Adverse Reaction
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cangene Plasma Resources, Mid-Florida

    Altamonte Springs, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Sept 2010
Primary completion
14 Feb 2012
Completion
14 Feb 2012
Last update posted
18 Mar 2024
Registered enrollment
25
Registry id
NCT01158157

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.